307 related articles for article (PubMed ID: 32951099)
1. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
2. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
3. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
4. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
5. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J
Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167
[TBL] [Abstract][Full Text] [Related]
6. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.
Riesco N; Cernuda-Morollón E; Martínez-Camblor P; Pérez-Alvarez AI; Verano L; García-Cabo C; Serrano-Pertierra E; Pascual J
Cephalalgia; 2017 Aug; 37(9):823-827. PubMed ID: 27250233
[TBL] [Abstract][Full Text] [Related]
8. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
9. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
12. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
13. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1α are elevated in pediatric migraine attacks.
Kilinc YB; Kilinc E; Danis A; Hanci F; Turay S; Ozge A; Bolay H
Headache; 2023 Sep; 63(8):1076-1086. PubMed ID: 37596867
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation.
Togha M; Ghorbani Z; Ramazi S; Zavvari F; Karimzadeh F
Front Neurol; 2021; 12():770980. PubMed ID: 35002925
[No Abstract] [Full Text] [Related]
16. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
17. Differences in Neuropathology between Nitroglycerin-Induced Mouse Models of Episodic and Chronic Migraine.
Park S; Jung H; Han SW; Lee SH; Sohn JH
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612517
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson's Disease.
Hu S; Huang S; Ma J; Li D; Zhao Z; Zheng J; Li M; Wang Z; Sun W; Shi X
Front Aging Neurosci; 2021; 13():689939. PubMed ID: 34566619
[No Abstract] [Full Text] [Related]
19. Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case-control study.
Al-Keilani MS; Almomani BA; Al-Sawalha NA; Al Qawasmeh M; Jaradat SA
Neurol Sci; 2022 Apr; 43(4):2621-2630. PubMed ID: 34698942
[TBL] [Abstract][Full Text] [Related]
20. Shared and independent roles of CGRP and PACAP in migraine pathophysiology.
Kuburas A; Russo AF
J Headache Pain; 2023 Apr; 24(1):34. PubMed ID: 37009867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]